Sanofi India gains after reporting decent Q2 results

Sanofi India rose 2.34% to Rs 3,600 at 11:00 IST on BSE after net profit rose 11.65% to Rs 64.20 crore on 7.76% rise in total income to Rs 559.60 crore in Q2 June 2015 over Q2 June 2014.

The result was announced after market hours yesterday, 21 July 2015.

Meanwhile, the BSE Sensex was up 158.79 points, or 0.56%, to 28,340.93.

On BSE, so far 325 shares were traded in the counter, compared with an average volume of 2,315 shares in the past one quarter.

Shares of pharma company hit a high of Rs 3,640 and a low of Rs 3,535.55 so far during the day. The stock had hit a record high of Rs 3,800 on 21 November 2014. The stock had hit a 52-week low of Rs 2,731 on 11 August 2014.

Sanofi India has declared an interim dividend of Rs 18 per share for the financial year ending 31 December 2015.

Sanofi India also announced after market hours yesterday, 21 July 2015, that the board of directors of the company has approved of the company selling its commercial property, being land admeasuring 5493.1 square meters (sq. mts.) bearing Survey No. 54-A Hissa No. 2 and C.T.S. No. 18 of Village Chakala, alongwith building known as 'Aventis House' standing thereon, situated at Sir Mathuradas Vasanji Road, Andheri (East) Mumbai - 400 093, for a consideration of Rs 11.10 crore. The built-up area of the building (comprising of basement and two upper floors) is approximately 69,600 square feet (sq. feet). The transaction is subject to certain conditions precedent and is expected to be completed in the quarter ending 30 September 2015.

Powered by Capital Market - Live News